View Author
scopus: 6603640314

Stoevelaar, H.

(Herman Stoevelaar)


policy database reimbursement health growth growth hormone hormone patient policy makers condition physician reimbursement policy practice guideline pharmaceutical dutch health insurers board drug use insurance prescription schedule network effect insurer maker study indication speci evidence number stakeholder bene fit package analysis policy questions netherland group treatment cholesterol control clopidogrel research question medicine measure therapy information protocol micro-level data taxol niezen cvz staff purpose medication result regulation 39–50 perspective growth hormone deficiency page number criteria specialist statin citation purposes thiazolidinedione focus groups technology example schedule 2 assessment requirement level staff effectiveness monitoring health insurance board check growth hormone database health insurance company volume




2 Most Recent Publications

Databases as policy instruments. about extending networks as evidence-based policy (Article)
Bont, A.A. de Stoevelaar, H. Bal, R.A.
2007-12-01
Conditional reimbursement within the Dutch drug policy (Article)
Niezen, M.G.H. Bont, A.A. de Stolk, E.A. Eyck, A. Niessen, L.W. Stoevelaar, H.
2007-11-01